URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Jacqueline Williams

Concepts (353)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Radiation Injuries
9
2004
131
4.710
Why?
Lung
11
1995
1148
2.910
Why?
Radiation-Protective Agents
5
2003
41
2.690
Why?
Nuclear Warfare
3
2011
7
2.500
Why?
Terrorism
3
2008
10
2.340
Why?
Radiation Pneumonitis
8
1995
43
2.240
Why?
Radiation Tolerance
7
1999
89
2.210
Why?
Lung Diseases
3
2011
224
2.140
Why?
Radiation Injuries, Experimental
10
1994
89
2.060
Why?
Whole-Body Irradiation
5
1999
87
1.800
Why?
Radiotherapy
5
2003
198
1.790
Why?
Radioactive Hazard Release
2
2012
4
1.720
Why?
Cytokines
9
1995
575
1.610
Why?
Radiation Protection
2
2010
23
1.540
Why?
Pulmonary Fibrosis
7
1996
139
1.230
Why?
Models, Animal
3
2010
140
1.180
Why?
National Institute of Allergy and Infectious Diseases (U.S.)
2
2012
5
1.080
Why?
Aging
4
2009
705
1.070
Why?
Acute Radiation Syndrome
2
2011
2
1.020
Why?
Disaster Planning
2
2008
11
0.980
Why?
Radiobiology
2
2009
10
0.930
Why?
Information Services
2
2003
24
0.930
Why?
Meninges
1
2012
21
0.860
Why?
Proto-Oncogene Proteins c-sis
1
2012
21
0.860
Why?
Cerebrospinal Fluid
1
2012
33
0.850
Why?
Surgical Procedures, Operative
2
2003
116
0.850
Why?
Drug Discovery
1
2012
11
0.850
Why?
Multiple Organ Failure
1
2011
37
0.790
Why?
Dose-Response Relationship, Radiation
10
1988
216
0.760
Why?
T-Lymphocytes
2
2011
564
0.750
Why?
Cell Proliferation
3
2010
520
0.740
Why?
Animals
41
1986
16416
0.730
Why?
Antineoplastic Agents
3
2003
628
0.730
Why?
Research
2
2009
185
0.720
Why?
Disease Models, Animal
5
1998
974
0.690
Why?
Nurses
1
2008
14
0.680
Why?
Environmental Exposure
2
2010
207
0.680
Why?
Nursing Care
1
2008
15
0.670
Why?
Homeostasis
1
2010
177
0.670
Why?
Neoplasms
3
2003
743
0.670
Why?
Radiation Dosage
9
1988
122
0.660
Why?
Carotid Stenosis
2
1999
52
0.660
Why?
Hospitals
1
2008
67
0.640
Why?
Mice, Inbred C57BL
16
1995
1700
0.640
Why?
Lung Neoplasms
2
2004
435
0.620
Why?
Brain
8
1994
1228
0.610
Why?
Emergency Medical Services
1
2008
139
0.590
Why?
Gene Expression Regulation, Developmental
1
2010
358
0.590
Why?
Humans
30
1998
37165
0.560
Why?
Mice
28
1986
6206
0.550
Why?
Biological Markers
6
2001
564
0.550
Why?
Lovastatin
1
2004
13
0.490
Why?
Peripheral Vascular Diseases
2
1999
27
0.450
Why?
United States
5
2008
2847
0.450
Why?
Animal Experimentation
2
2012
7
0.430
Why?
United States Food and Drug Administration
2
2012
46
0.420
Why?
Brachytherapy
3
1995
109
0.400
Why?
Prostaglandin-Endoperoxide Synthases
6
1998
170
0.380
Why?
Cell Aging
2
2010
55
0.350
Why?
Keloid
1
1999
4
0.350
Why?
Skin
5
1986
384
0.350
Why?
Neoplasms, Radiation-Induced
3
1986
80
0.340
Why?
Tunica Intima
4
1995
90
0.320
Why?
Breast Neoplasms
3
2003
666
0.310
Why?
Male
26
1986
20139
0.310
Why?
Isoenzymes
5
1998
448
0.310
Why?
Interleukin-1
5
1995
221
0.300
Why?
Lung Injury
3
1998
77
0.300
Why?
Skin Neoplasms
3
1986
230
0.290
Why?
Hyperplasia
7
1995
95
0.280
Why?
Interleukin-6
5
2001
339
0.280
Why?
Tumor Necrosis Factor-alpha
5
1996
694
0.260
Why?
Transforming Growth Factor beta
4
1995
411
0.260
Why?
Silicone Gels
2
2010
10
0.250
Why?
Catheterization
3
1998
124
0.240
Why?
Female
17
1986
20222
0.240
Why?
Encephalitis
2
2002
56
0.230
Why?
Adult
10
1999
11572
0.230
Why?
Blood-Brain Barrier
1
1994
110
0.230
Why?
Radioactive Fallout
1
2012
2
0.220
Why?
Age Distribution
2
2010
227
0.210
Why?
Licensure
1
2012
6
0.210
Why?
Survivors
2
2010
118
0.210
Why?
Vulnerable Populations
1
2012
25
0.210
Why?
Drug Evaluation, Preclinical
1
2012
79
0.210
Why?
Research Support as Topic
1
2012
55
0.210
Why?
Antigens, CD11c
1
2011
3
0.210
Why?
Implant Capsular Contracture
1
2011
4
0.200
Why?
Thoracic Neoplasms
2
2001
20
0.200
Why?
Aspergillus fumigatus
1
2011
4
0.200
Why?
Dose Fractionation
1
2011
57
0.200
Why?
Tai Ji
1
2011
22
0.200
Why?
Breast Implants
1
2010
13
0.190
Why?
Vascular Surgical Procedures
2
2000
67
0.190
Why?
Smad3 Protein
1
2011
73
0.190
Why?
Erythroid Cells
1
2011
23
0.190
Why?
Skull
1
2011
128
0.190
Why?
Stem Cell Transplantation
1
2012
115
0.190
Why?
Mice, Inbred C3H
8
1996
237
0.190
Why?
Combined Modality Therapy
1
2012
491
0.190
Why?
DNA Repair
2
2002
173
0.190
Why?
Cell Survival
1
2012
559
0.180
Why?
Macrophages
4
1998
347
0.180
Why?
Gene Expression Regulation
3
2002
895
0.180
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2010
436
0.180
Why?
Radiation Oncology
1
2009
18
0.180
Why?
Testicular Neoplasms
1
2010
55
0.180
Why?
Research Design
1
2012
340
0.180
Why?
Risk Assessment
2
2010
875
0.180
Why?
Rats
6
1990
4389
0.180
Why?
Polymorphism, Single Nucleotide
1
2010
90
0.180
Why?
Intercellular Adhesion Molecule-1
3
1997
119
0.180
Why?
Middle Aged
9
2001
10013
0.170
Why?
Microglia
3
1999
80
0.170
Why?
Comorbidity
1
2011
377
0.170
Why?
RNA, Messenger
8
1996
1893
0.170
Why?
Survival Rate
3
2004
619
0.170
Why?
Cell Transformation, Neoplastic
1
2010
138
0.170
Why?
Gene Expression Regulation, Neoplastic
1
2011
266
0.170
Why?
Faculty, Medical
1
2009
88
0.170
Why?
Prevalence
1
2011
582
0.170
Why?
Recurrence
3
1998
697
0.160
Why?
Rats, Sprague-Dawley
4
1995
1036
0.160
Why?
Time Factors
8
1996
3234
0.160
Why?
Muscle, Smooth, Vascular
3
1999
378
0.160
Why?
Teaching
1
2009
128
0.160
Why?
Astrocytes
4
1997
291
0.160
Why?
Young Adult
2
2010
1084
0.160
Why?
Fibroblast Growth Factor 2
2
1998
85
0.160
Why?
Insulin
1
2011
670
0.150
Why?
Aged
7
2001
7392
0.150
Why?
Cognition Disorders
1
2011
291
0.150
Why?
Health Care Surveys
1
2008
191
0.150
Why?
Prognosis
1
2011
1078
0.150
Why?
Chemokines
3
2002
112
0.150
Why?
Infant
2
2010
2320
0.150
Why?
Radiation, Ionizing
2
2002
35
0.140
Why?
Cyclooxygenase 2
6
1998
230
0.140
Why?
Silicosis
1
2006
12
0.140
Why?
Child, Preschool
2
2010
2737
0.140
Why?
Dinoprostone
2
2002
205
0.140
Why?
Dose-Response Relationship, Drug
3
2001
1142
0.140
Why?
Cross-Sectional Studies
1
2008
676
0.140
Why?
Silicon Dioxide
1
2006
87
0.140
Why?
Sulfonamides
2
2002
103
0.130
Why?
Antioxidants
1
2008
201
0.130
Why?
Clinical Competence
1
2008
270
0.130
Why?
Attitude of Health Personnel
1
2008
302
0.130
Why?
Cells, Cultured
1
2012
2589
0.130
Why?
Internship and Residency
1
2009
342
0.130
Why?
Health Knowledge, Attitudes, Practice
1
2008
296
0.130
Why?
Inflammation
2
2004
544
0.130
Why?
Cell Differentiation
1
2011
1127
0.130
Why?
Infant, Newborn
1
2010
1836
0.130
Why?
Intestines
1
2005
153
0.120
Why?
Radiodermatitis
1
2003
8
0.120
Why?
Child
2
2010
4342
0.120
Why?
Brain Edema
1
2004
46
0.120
Why?
Risk Factors
2
2002
2331
0.120
Why?
Prostaglandins
1
2004
67
0.120
Why?
Respiration
1
2004
181
0.120
Why?
Flurothyl
1
2003
5
0.110
Why?
Questionnaires
1
2008
1061
0.110
Why?
Cyclooxygenase Inhibitors
1
2003
66
0.110
Why?
Adolescent
2
2010
5044
0.110
Why?
Carotid Artery Injuries
2
1998
25
0.110
Why?
Mitosis
1
2003
101
0.110
Why?
Cyclin-Dependent Kinases
1
2002
39
0.110
Why?
Cyclins
1
2002
51
0.110
Why?
Bone Neoplasms
1
2004
208
0.100
Why?
Receptors, Chemokine
1
2002
43
0.100
Why?
Iridium Radioisotopes
2
1995
14
0.100
Why?
Beta Particles
4
1986
6
0.100
Why?
Signal Transduction
1
2011
1629
0.100
Why?
Monocytes
2
1999
317
0.100
Why?
Blood Vessel Prosthesis Implantation
1
2001
52
0.100
Why?
Carotid Arteries
2
1998
106
0.100
Why?
Gene Expression Regulation, Enzymologic
1
2002
193
0.100
Why?
Epilepsy
1
2003
166
0.090
Why?
Genome-Wide Association Study
2
2010
23
0.090
Why?
Platelet-Derived Growth Factor
2
1995
114
0.090
Why?
Transplantation Conditioning
1
1999
36
0.090
Why?
Vascular Diseases
1
2000
74
0.090
Why?
Oxygen
1
2002
495
0.090
Why?
Constriction, Pathologic
1
1999
77
0.090
Why?
Graft Occlusion, Vascular
1
1999
25
0.080
Why?
Radiotherapy Dosage
1
1999
202
0.080
Why?
Cyclophosphamide
1
1999
177
0.080
Why?
Aged, 80 and over
5
2001
2588
0.080
Why?
Femoral Artery
1
1999
75
0.080
Why?
Antigens, CD40
1
1998
55
0.080
Why?
Prostatic Neoplasms
1
2004
540
0.080
Why?
Bone Marrow Transplantation
1
1999
201
0.080
Why?
DNA Damage
2
2008
164
0.080
Why?
Transforming Growth Factor beta1
2
2005
78
0.080
Why?
Wound Healing
1
1999
213
0.080
Why?
Enzyme-Linked Immunosorbent Assay
3
2001
472
0.070
Why?
Pneumonia
1
1998
192
0.070
Why?
Neovascularization, Physiologic
1
1998
129
0.070
Why?
Chemokine CCL2
2
2002
128
0.070
Why?
Membrane Glycoproteins
1
1998
376
0.070
Why?
Carotid Artery, Common
1
1995
34
0.070
Why?
Gamma Rays
3
1996
69
0.060
Why?
Hydroxyproline
2
2002
23
0.060
Why?
Cell Division
3
1998
773
0.060
Why?
Horseradish Peroxidase
1
1994
29
0.060
Why?
Bone and Bones
1
1998
360
0.060
Why?
Apoptosis
2
2010
855
0.060
Why?
Mice, Knockout
2
2002
922
0.060
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
1999
543
0.060
Why?
Rats, Inbred Strains
1
1994
654
0.060
Why?
Muscle, Skeletal
1
1998
439
0.060
Why?
Bronchoalveolar Lavage Fluid
2
2002
301
0.050
Why?
Image Processing, Computer-Assisted
1
1994
262
0.050
Why?
Transcription, Genetic
1
1996
824
0.050
Why?
Clinical Trials as Topic
2
1999
685
0.050
Why?
Neutrophil Infiltration
1
2011
24
0.050
Why?
X-Ray Microtomography
1
2011
31
0.050
Why?
Linear Energy Transfer
1
2011
2
0.050
Why?
Necrosis
1
2011
103
0.050
Why?
Spores, Fungal
1
2011
4
0.050
Why?
BH3 Interacting Domain Death Agonist Protein
1
2011
12
0.050
Why?
Microradiography
1
2010
6
0.050
Why?
bcl-2-Associated X Protein
1
2011
55
0.050
Why?
bcl-X Protein
1
2011
41
0.050
Why?
Erythroblasts
1
2011
38
0.050
Why?
Platinum Compounds
1
2010
7
0.050
Why?
Paresthesia
1
2010
18
0.050
Why?
Inflammation Mediators
1
2011
113
0.050
Why?
Interleukin-8
1
2011
111
0.050
Why?
Renal Insufficiency
1
2010
20
0.050
Why?
Energy Transfer
1
1990
29
0.050
Why?
Electrons
1
1990
12
0.050
Why?
Body Weight
1
2011
337
0.050
Why?
Infertility, Male
1
2010
35
0.050
Why?
Collagen
2
1995
301
0.050
Why?
Employment
1
2010
70
0.050
Why?
Mice, Inbred CBA
1
1990
138
0.050
Why?
Dendritic Cells
1
2011
117
0.050
Why?
Teaching Materials
1
2009
12
0.050
Why?
Genetic Markers
1
2010
132
0.040
Why?
Biophysics
1
2009
61
0.040
Why?
Accreditation
1
2009
19
0.040
Why?
Canada
1
2009
77
0.040
Why?
Pilot Projects
1
2011
446
0.040
Why?
Population Surveillance
1
2010
144
0.040
Why?
Mentors
1
2009
29
0.040
Why?
Cell Cycle
1
2011
253
0.040
Why?
Terminology as Topic
1
2010
108
0.040
Why?
Neutrophils
1
2011
313
0.040
Why?
Fatigue
1
2010
124
0.040
Why?
Forecasting
1
2009
188
0.040
Why?
Educational Status
1
2009
182
0.040
Why?
Analysis of Variance
1
2011
749
0.040
Why?
Prospective Studies
2
2001
1696
0.040
Why?
Endothelial Cells
1
2011
211
0.040
Why?
Societies, Medical
1
2009
142
0.040
Why?
Double-Blind Method
1
2011
996
0.040
Why?
Evidence-Based Medicine
1
2010
210
0.040
Why?
Models, Statistical
1
2010
222
0.040
Why?
Neoplasms, Second Primary
1
2010
125
0.040
Why?
Flow Cytometry
1
2011
603
0.040
Why?
Educational Measurement
1
2009
123
0.040
Why?
Neoplasm Recurrence, Local
1
2010
295
0.040
Why?
Cognition
1
2010
232
0.040
Why?
Genetic Predisposition to Disease
1
2010
317
0.040
Why?
Membrane Proteins
2
1998
560
0.040
Why?
Magnetic Resonance Imaging
1
1994
1019
0.040
Why?
Incidence
1
2010
682
0.040
Why?
Cardiovascular Diseases
1
2010
275
0.040
Why?
Oropharynx
1
2006
11
0.040
Why?
Practice Guidelines as Topic
1
2009
319
0.040
Why?
Tomography, X-Ray Computed
1
2010
785
0.030
Why?
Oxidative Stress
1
2010
347
0.030
Why?
Administration, Inhalation
1
2006
172
0.030
Why?
Quality of Life
1
2010
528
0.030
Why?
Age Factors
1
2009
1152
0.030
Why?
Transforming Growth Factor beta2
1
2005
4
0.030
Why?
Transforming Growth Factor beta3
1
2005
4
0.030
Why?
Intubation, Intratracheal
1
2006
95
0.030
Why?
Mice, Inbred DBA
1
2005
92
0.030
Why?
Cyclooxygenase 1
1
2005
71
0.030
Why?
ROC Curve
1
2005
130
0.030
Why?
Treatment Outcome
2
2001
2671
0.030
Why?
Orchiectomy
1
2004
38
0.030
Why?
Antineoplastic Agents, Hormonal
1
2004
44
0.030
Why?
Tissue Distribution
1
2004
240
0.030
Why?
Xenograft Model Antitumor Assays
1
2003
46
0.030
Why?
Androgen Antagonists
1
2004
63
0.030
Why?
Cyclooxygenase 2 Inhibitors
1
2003
62
0.030
Why?
Pyrazoles
1
2003
59
0.030
Why?
Convulsants
1
2003
14
0.030
Why?
Interferon-gamma
1
2005
341
0.030
Why?
Lipopolysaccharides
1
2004
211
0.030
Why?
Bromodeoxyuridine
1
2003
68
0.030
Why?
Dentate Gyrus
1
2003
26
0.030
Why?
Predictive Value of Tests
1
2005
609
0.030
Why?
Anastomosis, Surgical
1
2002
70
0.030
Why?
Nitrobenzenes
1
2002
28
0.030
Why?
Chemokine CXCL2
1
2002
66
0.030
Why?
In Situ Nick-End Labeling
1
2002
96
0.030
Why?
Liver Neoplasms
1
2004
155
0.030
Why?
Neoplasm Staging
1
2004
354
0.030
Why?
Matrix Metalloproteinase 9
1
2002
59
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2002
71
0.030
Why?
Cell Count
1
2003
287
0.030
Why?
Cell Culture Techniques
1
2002
94
0.030
Why?
Sheep
1
2001
79
0.030
Why?
In Situ Hybridization
1
2002
332
0.030
Why?
Polytetrafluoroethylene
1
2001
39
0.030
Why?
Sensitivity and Specificity
1
2005
914
0.030
Why?
Vascular Patency
1
2001
67
0.030
Why?
Nitric Oxide Synthase
1
2002
163
0.030
Why?
Hippocampus
1
2003
216
0.020
Why?
Tumor Suppressor Protein p53
1
2002
140
0.020
Why?
Behavior, Animal
1
2003
239
0.020
Why?
Cell Line, Tumor
1
2003
576
0.020
Why?
Brain Neoplasms
1
2004
282
0.020
Why?
Animals, Newborn
1
2002
502
0.020
Why?
Angioplasty, Balloon
1
2000
70
0.020
Why?
Severity of Illness Index
1
2004
943
0.020
Why?
Arteriosclerosis
1
2000
97
0.020
Why?
Peroxidases
1
1999
26
0.020
Why?
Culture Media, Conditioned
1
1999
66
0.020
Why?
Kinetics
1
2002
1471
0.020
Why?
Mast Cells
1
1998
48
0.020
Why?
Evaluation Studies as Topic
1
1999
247
0.020
Why?
Transplantation, Homologous
1
1999
280
0.020
Why?
CD40 Ligand
1
1998
93
0.020
Why?
Laser-Doppler Flowmetry
1
1998
20
0.020
Why?
Iodine Radioisotopes
1
1998
104
0.020
Why?
Hindlimb
1
1998
57
0.020
Why?
DNA Primers
1
1999
422
0.020
Why?
Cricetinae
1
1998
393
0.020
Why?
Rabbits
1
1999
720
0.020
Why?
Regional Blood Flow
1
1998
186
0.020
Why?
Retrospective Studies
1
2004
2302
0.020
Why?
Cerebrovascular Circulation
1
1997
117
0.020
Why?
Cell Adhesion
1
1998
270
0.020
Why?
Cesium Radioisotopes
1
1996
29
0.020
Why?
Thorax
1
1996
32
0.020
Why?
Disease Susceptibility
1
1996
80
0.020
Why?
Microscopy, Electron, Scanning Transmission
1
1995
3
0.020
Why?
Follow-Up Studies
1
2001
1889
0.020
Why?
Microscopy, Electron, Scanning
1
1995
120
0.020
Why?
Immunity, Innate
1
1996
103
0.020
Why?
Cell Movement
1
1998
378
0.020
Why?
Antibodies, Monoclonal
1
1998
748
0.020
Why?
Fibronectins
1
1995
151
0.020
Why?
Endothelium, Vascular
1
1997
454
0.010
Why?
Neurons
1
1999
1105
0.010
Why?
Stochastic Processes
1
1988
42
0.010
Why?
Swine
1
1986
182
0.010
Why?

Visualizations


Williams's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department